Andrew Moreo
Head of Process Development • Andelyn Biosciences
Andrew Moreo, provides daily control as well as strategic guidance for the process development. He ensures that all activities within the process development and preclinical manufacturing teams. He ensures that all activities within the process development are within compliance standards. Mr. Moreo has over 20 years of experience in genetic and molecular research. He has worked for RINCH for the past 13 years focusing on AAV including the development of the current AAV production platform. Mr. Moreo has a BS in Biology from Purdue University
Also Speaking
Branden Salinas
Senior Director Manufacturing Sciences and Technology • Umoja Biopharma
6 December 2022
Kristy Shipulski
Vice President, Supply Chain Management • Vertex Cell and Gene Therapies
31 October 2022
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023
